Potent inhibition of human gastric cancer by HER2-directed induction of apoptosis with anti-HER2 antibody and caspase-3 fusion protein (vol 59, pg 292, 2010)

被引：0
|
作者：
Zhang, De-Xin
Zhao, Peng-Tao
Xia, Lin
机构：
来源：
GUT | 2010年 / 59卷 / 07期
关键词：
D O I：
10.1136/gut.2008.155226corr1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
下载
收藏
页码：1007 / 1007
页数：1
相关论文
共 28 条
  • [1] Potent inhibition of human gastric cancer by HER2-directed induction of apoptosis with anti-HER2 antibody and caspase-3 fusion protein
    Zhang, De-Xin
    Zhao, Peng-Tao
    Xia, Lin
    Liu, Li-Li
    Liang, Jie
    Zhai, Hui-Hong
    Zhang, Hong-Bo
    Guo, Xue-Gang
    Wu, Kai-Chun
    Xu, Yan-Ming
    Jia, Lin-Tao
    Yang, An-Gang
    Chen, Si-Yi
    Fan, Dai-Ming
    GUT, 2010, 59 (03) : 292 - 299
  • [2] Suppression of tumor growth in human gastric cancer with HER2 overexpression by an anti-HER2 antibody in a murine model
    Matsui, Y
    Inomata, M
    Tojigamori, M
    Sonoda, K
    Shiraishi, N
    Kitano, S
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2005, 27 (03) : 681 - 685
  • [3] Characterization of a RANTES anti-HER2/neu antibody fusion protein for cancer immunotherapy.
    Challita-Eid, PM
    Abboud, CN
    Morrison, SL
    Hilchey, SP
    Penichet, ML
    Rosebrough, SF
    Rosenblatt, JD
    BLOOD, 1998, 92 (10) : 24A - 24A
  • [4] An anti-HER2 antibody conjugated with monomethyl auristatin E is highly effective in HER2-positive human gastric cancer
    Li, Hongwen
    Yu, Chao
    Jiang, Jing
    Huang, Changjiang
    Yao, Xuejing
    Xu, Qiaoyu
    Yu, Fang
    Lou, Liguang
    Fang, Jianmin
    CANCER BIOLOGY & THERAPY, 2016, 17 (04) : 346 - 354
  • [5] BAT8001, a potent anti-HER2 antibody-drug conjugate with a novel stable linker for the treatment of HER2-positive gastric cancer
    Yu, J. C.
    Tang, W.
    Deng, X.
    Ou, Z.
    Gan, J.
    Dong, Q.
    Tan, B.
    Lu, L.
    Chen, B.
    Bao, C.
    Thomas, B.
    Li, S.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E50 - E51
  • [6] Development of an anti-HER2 antibody-NKG2D ligand fusion protein for breast cancer therapy.
    Shin, S-U
    Cho, H-M
    Tolba, K.
    Calfa, C.
    Shin, S. J.
    Zhang, Y.
    Rosenblatt, J. D.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S30 - S30
  • [7] Anti-HER2 monoclonal antibodies intensify the susceptibility of human gastric cancer cells to etoposide by promoting apoptosis, but not autophagy
    Gornowicz, Agnieszka
    Szymanowski, Wojciech
    Czarnomysy, Robert
    Bielawski, Krzysztof
    Bielawska, Anna
    PLOS ONE, 2021, 16 (08):
  • [8] Insights into the mechanism of anti-tumor immunity in mice vaccinated with the human HER2/neu extracellular domain plus anti-HER2/neu IgG3-(IL-2) or anti-HER2/neu IgG3-(GM-CSF) fusion protein
    Dela Cruz, JS
    Morrison, SL
    Penichet, ML
    VACCINE, 2005, 23 (39) : 4793 - 4803
  • [9] Fusion of apoptosis-related protein Cytochrome c with anti-HER-2 single-chain antibody targets the suppression of HER-2+breast cancer
    Lu, DanDan
    Guo, YiChen
    Hu, YunFeng
    Wang, Min
    Li, Chen
    Gangrade, Abhishek
    Chen, JiaHui
    Zheng, ZiHui
    Guo, Jun
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (22) : 10638 - 10649
  • [10] Recombinant humanized anti-HER2 antibody (Herceptin™) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts (vol 58, pg 2825, 1998)
    Baselga, J
    Norton, L
    Albanell, J
    Kim, YM
    Mendelsohn, J
    CANCER RESEARCH, 1999, 59 (08) : 2020 - 2020
123